Replies to post #391459 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

Someone’s in a lot of Securities Law trouble today.

Reg FD is not to be sniffed at.

[threebabiesbusy]

Does anyone have access to FDA’s direct feedback of study results for phase 2?

July 22, 2022 / ACCESSWIRE Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provided an update on the Company’s Brilacidin program in Oral Mucositis (OM). Brilacidin, delivered as an oral rinse, was shown in Phase 2 clinical testing (NCT02324335) to reduce incidence, delay onset and decrease duration of severe OM (WHO Grade ≥ 3) in Head and Neck Cancer (HNC) patients receiving chemoradiation. The Company and FDA have completed an End-of-Phase 2 meeting and agreed to an acceptable Phase 3 program.

[attilathehunt]

"The Company and FDA have completed an End-of-Phase 2 meeting and agreed to an acceptable Phase 3 program. "

How long would a P3 be?